Vanda Reports Positive Results From Study 3601 of Tradipitant
The company said tradipitant significantly reduced semaglutide-induced vomiting, including frequent multi-day and extreme episodes.
Related stories
Asian session market picture: S&P 500 -1.04%, Nasdaq 100 -2.25%; USD/JPY -0.12%, WTI +1.81%, 1810 leads volume
Asian session market picture. US index futures: S and P futures is down 1.04 percent, Nasdaq futures is down 2.25 percent, Dow futures is down 0.26 percent and Russell futures is d
M impact | EQUITY | Oct 30, 2026, 02:30 AM UTC
Geely Auto Quarterly Earnings Rise 28% Amid Overhaul
Geely Auto reported a 28% jump in quarterly earnings. The commentary says the market continues to treat the Chinese automaker poorly despite changes to electrification, succession
M impact | EQUITY | Oct 30, 2026, 02:27 AM UTC
Aluminum Corp of China H Shares Rise 2.7% as Q3 Net Profit Climbs
Aluminum Corp of China’s H shares rose 2.7%; its A shares gained as much as 1.8% Friday morning. Third-quarter net profit increased year over year.
M impact | EQUITY | Oct 30, 2026, 02:26 AM UTC
Junshi Biosciences Q3 Revenue Rises 39.2%
Junshi Biosciences reported a 39.2% increase in revenue in its third-quarter report.
M impact | EQUITY | Oct 30, 2026, 02:25 AM UTC
Jakarta Stocks Fall 1.7%
M impact | EQUITY | Oct 30, 2026, 02:21 AM UTC
Indian Shares Seen Opening Higher After Earnings-Led Rebound
Indian shares are seen opening higher after an earnings-led rebound, with higher oil expected to cap gains.
M impact | EQUITY | Oct 30, 2026, 02:20 AM UTC